The Zacks Analyst Blog Highlights: UnitedHealth Group, Accenture, Nokia, Siemens and IBM

   The Zacks Analyst Blog Highlights: UnitedHealth Group, Accenture, Nokia,
                               Siemens and IBM

PR Newswire

CHICAGO, Oct. 3, 2012

CHICAGO, Oct. 3, 2012 /PRNewswire/ --Zacks.com announces the list of stocks
featured in the Analyst Blog. Every day the Zacks Equity Research analysts
discuss the latest news and events impacting stocks and the financial markets.
Stocks recently featured in the blog include UnitedHealth Group Inc.
(NYSE:UNH), Accenture plc (NYSE:ACN), Nokia Corporation (NYSE:NOK), Siemens AG
(NYSE:SI) and IBM Corp. (NYSE:IBM).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit
from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday's Analyst Blog:

UNH Discloses 2013 Medicare Plans

UnitedHealthcare – the health benefits segment ofUnitedHealth Group Inc.
(NYSE:UNH) – has come out with its Medicare portfolio for 2013. It has also
disclosed a low-cost Part-D Plan as well as its preferred pharmacy network,
which will enable its Medicare consumers to achieve greater cost benefits. The
company offers its Medicare plans under the American Association of Retired
Persons (AARP) brand.

UnitedHealth has devised its plan in such a way that it attracts baby boomers
who have already became eligible for Medicare last year, and also provide
better service to its current 49 million beneficiaries. The company's Medicare
products are also planned to offer stability, value and reliability to its
more than 10 million plan participants.

Current Medicare beneficiaries have the option to make changes to their
current health plans during the Open Enrollment Period, which will start from
October 15, 2012. 

UnitedHealthcare will launch the AARP MedicareRx Saver Plus (PDP) plan. The
new plan with $15 premium will be the lowest lowest-cost Part D prescription
drug plan and will enable consumers to save on both their monthly premium as
well as on their prescription copays.

Accenture Boosts Video Capabilities

Management technology outsourcing and consulting service provider, Accenture
plc (NYSE:ACN) recently took over certain Internet Protocol television (IPTV)
assets of Nokia Siemens Networks for an undisclosed amount. Nokia Siemens
Networks is a 50-50 joint venture between Nokia Corporation (NYSE:NOK) and
Siemens AG (NYSE:SI). The assets of its IPTV business include software and
intellectual properties.

The IPTV assets were expected to solidify Accenture's Video Solution, which is
a software platform facilitating seamless and cost-effective distribution of
web-based video services.

Accenture expects to easily integrate the IPTV software business into its
existing video services suite. The combined technology is then expected to
deliver enhanced video and TV services through the IP network. The services
can be accessed from any network connection and viewed using various devices
such as smartphones, tablets, PCs and TVs. Users can also pause and record a
program.

All things considered, the solution should be of immense value for the
telecom, video content and online entertainment services providers that can
enhance the web-based content viewing experience for their respective
customers.

Accenture has years of experience in delivering video solutions. We believe
that with a revamped portfolio, Accenture will be able to acquire newer
customers while proving its excellence in the arena going forward.

Accenture seems to be on an acquisition spree. In August, the company acquired
Singapore-based distributor management and mobility software company NewsPage
Pte Ltd. and Octagon Research Solutions Inc., a reputed software solutions
provider for the life sciences sector.

We are encouraged by Accenture's strategy of growing through acquisitions.
However, increasing competition from IBM Corp. (NYSE:IBM), a strained spending
environment and Accenture's broad European exposure (roughly 40.0%) may temper
its growth prospects to some extent.

Currently, Accenture has a Zacks #2 Rank (short-term Buy rating), which has
been driven by upward revisions to analyst estimates.

Want more from Zacks Equity Research? Subscribe to the free Profit from the
Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative
analysis to help investors know what stocks to buy and which to sell for the
long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded
stocks. Our analysts are organized by industry which gives them keen insights
to developments that affect company profits and stock performance.
Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the
latest analysis from Zacks Equity Research. Subscribe to this free newsletter
today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results. Amongst his
many accomplishments was the formation of his proprietary stock picking
system; the Zacks Rank, which continues to outperform the market by nearly a 3
to 1 margin. The best way to unlock the profitable stock recommendations and
market insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your free
subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook:
http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
any security.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com



SOURCE Zacks Investment Research, Inc.

Website: http://www.zacks.com
 
Press spacebar to pause and continue. Press esc to stop.